Irinotecan in Treating Aging Patients With Solid Tumors
NCT00026195
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
140
Enrollment
OTHER
Sponsor class
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG:
irinotecan hydrochloride
Sponsor
Alliance for Clinical Trials in Oncology
Collaborators
[object Object]